A major breakthrough in cancer investigation is emerging with the use of nanobodies to reactivate dysfunctional p53. This essential tumor inhibitor protein is frequently inactivated in many kinds of malignancies, https://crossbookmark.com/story21810077/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-hope-for-cancer-management